Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients

In this multicenter, prospective, randomized controlled study, we aimed to figure out, compared with the global chronic obstructive pulmonary disease initiative (GOLD) guideline -guided antibiotic therapy, whether Interleukin 6 (IL6)-guided antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can lead to a reduction in the use of antibiotics without increasing the rate of treatment failure.

NCT Number	NCT06612476
Lead Sponsor	Ningbo No. 1 Hospital
Conditions	Chronic Obstructive Pulmonary Disease, COPD
Enrollment	440 participants
Start Date	2024-09-20
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2024-09-25